Literature DB >> 24803041

Limited role for biliary stent as surrogate fiducial marker in pancreatic cancer: stent and intratumoral fiducials compared.

Astrid van der Horst1, Eelco Lens2, Silvia Wognum2, Rianne de Jong2, Jeanin E van Hooft3, Geertjan van Tienhoven2, Arjan Bel2.   

Abstract

PURPOSE: Because of low soft-tissue contrast of cone beam computed tomography (CBCT), fiducial markers are often used for radiation therapy patient setup verification. For pancreatic cancer patients, biliary stents have been suggested as surrogate fiducials. Using intratumoral fiducials as standard for tumor position, this study aims to quantify the suitability of biliary stents for measuring interfractional and respiratory-induced position variations of pancreatic tumors. METHODS AND MATERIALS: Eleven pancreatic cancer patients with intratumoral fiducials and a biliary stent were included in this study. Daily CBCT scans (243 in total) were registered with a reference CT scan, based on bony anatomy, on fiducial markers, and on the biliary stent, respectively. We analyzed the differences in tumor position (ie, markers center-of-mass position) among these 3 registrations. In addition, we measured for 9 patients the magnitude of respiratory-induced motion (MM) of the markers and of the stent on 4-dimensional CT (4DCT) and determined the difference between these 2 magnitudes (ΔMM).
RESULTS: The stent indicated tumor position better than bony anatomy in 67% of fractions; the absolute difference between the markers and stent registration was >5 mm in 46% of fractions and >10 mm in 20% of fractions. Large PTV margins (superior-inferior direction, >19 mm) would be needed to account for this interfractional position variability. On 4DCT, we found in superior-inferior direction a mean ΔMM of 0.5 mm (range, -2.6 to 4.2 mm).
CONCLUSIONS: For respiratory-induced motion, the mean ΔMM is small, but for individual patients the absolute difference can be >4 mm. For interfractional position variations, a stent is, on average, a better surrogate fiducial than bony anatomy, but large PTV margins would still be required. Therefore, intratumoral fiducials are recommended for online setup verification for all pancreatic patients scheduled for radiation therapy, including patients with a biliary stent.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24803041     DOI: 10.1016/j.ijrobp.2014.03.029

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer : The dummy run.

Authors:  Eva Versteijne; Eelco Lens; Astrid van der Horst; Arjan Bel; Jorrit Visser; Cornelis J A Punt; Mustafa Suker; Casper H J van Eijck; Geertjan van Tienhoven
Journal:  Strahlenther Onkol       Date:  2017-06-12       Impact factor: 3.621

2.  Identification of research trends concerning application of stent implantation in the treatment of pancreatic diseases by quantitative and biclustering analysis: a bibliometric analysis.

Authors:  Xuan Zhu; Xing Niu; Tao Li; Chang Liu; Lijie Chen; Guang Tan
Journal:  PeerJ       Date:  2019-10-24       Impact factor: 2.984

3.  EUS-guided fiducial placement for pancreatobiliary malignancies: safety, infection risk, and use of peri-procedural antibiotics.

Authors:  Madhuri Chandnani; Mir Fahad Faisal; Jeremy Glissen-Brown; Mandeep Sawhney; Douglas Pleskow; Jonah Cohen; Tyler M Berzin
Journal:  Endosc Int Open       Date:  2020-01-22

4.  Dosimetric effects of anatomical changes during fractionated photon radiation therapy in pancreatic cancer patients.

Authors:  Astrid van der Horst; Antonetta C Houweling; Geertjan van Tienhoven; Jorrit Visser; Arjan Bel
Journal:  J Appl Clin Med Phys       Date:  2017-10-04       Impact factor: 2.102

5.  Extensive Unpredictable Pancreas Cancer Inter-fraction Motion: A Case Report.

Authors:  Sangjune L Lee; Michael Velec; Pablo Munoz-Schuffenegger; Teo Stanescu; Laura Dawson
Journal:  Cureus       Date:  2019-06-30

6.  EUS-guided placement of fiducial markers for image-guided radiotherapy in gastrointestinal tumors: A critical appraisal.

Authors:  Silvia Carrara; Mihai Rimbas; Alberto Larghi; Milena Di Leo; Tiziana Comito; Joseph Abi Jaoude; Cullen M Taniguchi; Christoph F Dietrich; Manoop S Bhutani; Stephan Hollerbach
Journal:  Endosc Ultrasound       Date:  2021 Nov-Dec       Impact factor: 5.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.